Received Jan 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | k4979 | IM / RA |
low grade fever; hurt abdomen; injection site is aggravated by typing /deep pain at injection site when typing or moving arm; she fell walking by a construction site.; hurt knees; scraped right hand; This non-serious case was reported by a nurse and described the occurrence of injection site pain in a 51-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number k4979, expiry date 27-MAR-2028) for prophylaxis. Previously administered products included COVID injection with an associated reaction of dysgeusia (Consumer states when she has a COVID injection (manufacturer not disclosed/frequency) she tastes metal in her mouth/jaw. She describes this as having a mouthful of nickels.), pseudoephedrine with an associated reaction of palpitations and pneumonia vaccine. Concurrent medical conditions included celiac disease, diabetes, high cholesterol, hypertension, allergy to NSAID'S (Consumer states she will break out in hives) and allergy. On 26-NOV-2025 11:00, the patient received Boostrix. On 26-NOV-2025, less than a day after receiving Boostrix, the patient experienced fall (Verbatim: she fell walking by a construction site.), knee pain (Verbatim: hurt knees), abrasion (Verbatim: scraped right hand) and abdominal pain (Verbatim: hurt abdomen). On an unknown date, the patient experienced injection site pain (Verbatim: injection site is aggravated by typing /deep pain at injection site when typing or moving arm) and low-grade fever (Verbatim: low grade fever). On 26-NOV-2025, the outcome of the fall was resolving, and the outcome of the knee pain, abrasion and abdominal pain were resolved. The outcome of the injection site pain and low grade fever was unknown. It was unknown if the reporter considered the injection site pain, fall, knee pain, abrasion, low grade fever and abdominal pain to be related to Boostrix. It was unknown if the company considered the injection site pain, fall, knee pain, abrasion, low grade fever and abdominal pain to be related to Boostrix. Additional Information: GSK receipt date:09-JAN-2026 Patient was vaccinated with shingles vaccine. The batch number was provided and follow up consent was provided. The consumer also states patient had a low-grade fever that was detected by her Ultra Ring
Allergy to NSAIDs (consumer states she will break out in hives); Blood cholesterol increased; Celiac disease; Diabetes; Food allergy (allergy to oregano); Hypertension